A5036296184- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Viral-associated cancers and disorders
- Acute Myeloid Leukemia Research
- Musculoskeletal pain and rehabilitation
- Lung Cancer Treatments and Mutations
- Posttraumatic Stress Disorder Research
- Multiple and Secondary Primary Cancers
- Immunodeficiency and Autoimmune Disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Acute Lymphoblastic Leukemia research
- MicroRNA in disease regulation
- Sarcoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Cancer Diagnosis and Treatment
- Patient-Provider Communication in Healthcare
- Neutropenia and Cancer Infections
- Generational Differences and Trends
- Empathy and Medical Education
- Hemoglobinopathies and Related Disorders
- Cancer survivorship and care
- Cutaneous lymphoproliferative disorders research
Klinička bolnica Merkur
2013-2025
John Wiley & Sons (United States)
2019
Hudson Institute
2019
Georgetown University
2016-2017
Georgetown University Medical Center
2016-2017
University Hospital Centre Zagreb
2016
University of Kragujevac
2013
Northern State Medical University
2013
University of Zagreb
2007-2011
This multicenter retrospective study included 101 patients (median age 62 years) with secondary plasma cell leukemia (sPCL). The median time from initial multiple myeloma diagnosis to sPCL was 31 months. Fifty-five out of 72 (75%) who received any therapy were treated immunomodulators (IMiDs) and/or proteasome inhibitors (PIs), and 14/72 (19%) underwent salvage autologous stem transplantation (ASCT). overall response rate in ASCT or PI (either alone combination) higher than those did not...
The current study assesses the characteristics and outcomes of multiple myeloma (MM) patients, treated with novel agents for hematogenous extramedullary (HEMM) relapse. Consecutive patients diagnosed HEMM between 2010-2018 were included. Patients' at diagnosis presentation, response to treatment, survival factors predicting recorded analyzed. A group 127 all by imaging (87.3%) and/or biopsy (79%), Of those, 44% initially ISS3, 57% presented plasmacytomas, 30% had high-risk cytogenetics....
Background/Objectives: In hematological patients receiving treatment for lymphomas, febrile neutropenia (FN) is a serious complication associated with significant morbidity and mortality. This prospective study aimed to evaluate the diagnostic prognostic value of novel biomarker presepsin (PSP) in episodes FN this specific cohort patients. Methods: The enrolled 37 18 without fever as control group. Patients were divided into two groups: those confirmed infections them. Various clinical...
The aim of this study was to investigate the quality life in Croatian homeland war veterans who suffer from post-traumatic stress disorder and chronic low back pain (LBP).A total 369 participants were included, classified four groups: those with (PTSD; N = 59), both PTSD lower (PTSD+LBP; 80), isolated LBP (N 95) controls 135). WHOQOL-BREF survey used estimation life. data analysed using statistical methods hierarchical clustering.The results indicated a general pattern lowering psychological...
A small proportion of patients with multiple myeloma (MM) are diagnosed at a very young age. The clinicopathological characteristics and prognosis these not well known. This analysis included 52 MM the age ≤30 years (range: 8–30 years). 68% had International Scoring System (ISS) 1 MM; 22% presented light chain-only disease, 48% elevated serum lactate dehydrogenase (LDH). 85% were treated novel agents, 62% received front-line autologous stem cell transplantation (ASCT). Overall response rate...
One of the main conceptual changes in 20th century medicine is inclusion social dimension. The “golden era” Parson’s medical model (1), which uses “active-passive” dichotomy to describe positions and expectations physicians patients, over. Physicians’ supremacy has slowly systematically been challenged by emergence third party stakeholders, development new media sources, strengthening civil society, democratization information, all have contributed patients’ active role healing processes...
Background: There is an increased risk of second primary malignancies (SMPs) in patients with multiple myeloma (MM). This multinational ‘real-world’ retrospective study analyzed the characteristics and outcomes MM that developed SPMs. Results: 165 were analyzed: 62.4% males; 8.5% a prior cancer; 113 solid SPMs, mainly ≥stage 2; 52 hematological SPM (hemato-SPM), MDS/AML. Patients hemato-SPM younger (p = 0.05) more frequently had AutoHCT 0.012). The time to was shorter older (>65 years)...
Patients with cancer should be systematically screened for psychological problems at key points in their pathway. Usage of self-report scales measuring anxiety and depression (such as Hospital Anxiety Depression scale (HADS)) is a very practical methodfor detecting depression. The aim this research was to determine latent structure, reliability cut-off scores HADSin Croatian sample adult patients suffering from advanced metastatic cancer.According inclusion exclusion criteria, participant...
Obinutuzumab (G) has become part of front-line treatment follicular lymphoma (FL) based on results a large randomized study. Data patients treated outside clinical trials are lacking. We have retrospectively investigated efficacy and safety G-based immunochemotherapy regimens in 114 real-life setting during period 2 years, largely coinciding with the COVID-19 pandemic. The response rate was 93.8%; 18-months overall (OS) progression-free survival (PFS) were 88% 84%, respectively. Patients...
Hodgkin lymphoma is characterized by a high cure rate in the modern era of medicine regardless stage, but patients suffer from risk comorbidity associated with administered therapy. The main aim this review article to assess and analyze various comorbidities address survivorship patients, including fertility, secondary cancers due cardiovascular toxicity, quality life. Furthermore, explores optimal strategy for detecting relapse. treatment paradigm has shifted, shift toward achieving low...
In this observational study, direct and indirect (moderator mediator) relationships between sociodemographic (age, gender, life partner, education level, income length of treatment) psychological (Hospital Anxiety Depression Scale, HADS) variables satisfaction with hospital care (EORTC INPATSAT32) in adult (advanced cancer) patients were investigated.Study sample consisted 75 hospitalized advanced cancer recruited at the Zagreb University Hospital Centre Sestre milosrdnice 2015.Statistically...
Background/Objectives: Obinutuzumab was approved for front-line treatment of chronic lymphocytic leukemia in combination with chlorambucil pulses administered every 2 wks. Alternative schedules enable the administration higher total doses, and have better antileukemia activity. So far, evidence on feasibility combining obinutuzumab alternative is lacking. We performed this retrospective analysis to analyze real life outcomes patients receiving a different schedules. Methods: This survey...